Cengiz Tarhan，英国伦敦大学商业化公司总监。Having trained as an accountant, after a spell at University of London Cengiz joined the Royal Free Hospital School of Medicine (RFHSM) in 1989. In 1993 he was appointed as Finance Director for RFHSM and then continued as Director of Financial and Business Affairs for the Medical School on its merger with UCL in 1998. Cengiz established Freemedic PLC (now UCL Business PLC (UCLB)) as the commercial arm of RFHSM in 1993 and formally transferred from his UCL role to the position of Managing Director for UCLB in 2004. Over the years he has been involved in many licences and spin-outs including PolyMASC Pharmaceuticals PLC, one of the first university spin-outs to float on the AIM in 1995, Medic to Medic Ltd (creators of the Map of Medicine) which was sold to Informa PLC in 2005 and Stanmore Implants Worldwide Limited which was acquired by Abingworth and MDY Healthcare in February 2008. Cengiz also acts as a Director for a number of UCLB’s spinout companies, including Pentraxin Therapeutics Limited, Evexar Medical Limited and the Bloomsbury BioSeed Fund as well as acting as advisor to a number of international technology transfer organisations and universities.